Literature DB >> 28042702

Effect of doxycycline and ursodeoxycholic acid on transthyretin amyloidosis.

Jonas Wixner1, Björn Pilebro1, Hans-Erik Lundgren1, Malin Olsson1, Intissar Anan1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 28042702     DOI: 10.1080/13506129.2016.1269739

Source DB:  PubMed          Journal:  Amyloid        ISSN: 1350-6129            Impact factor:   7.141


× No keyword cloud information.
  7 in total

Review 1.  Targeted treatments of AL and ATTR amyloidosis.

Authors:  Pranav Chandrashekar; Anish K Desai; Barry H Trachtenberg
Journal:  Heart Fail Rev       Date:  2021-11-16       Impact factor: 4.654

Review 2.  Amyloidosis in Heart Failure.

Authors:  Sandra Ihne; Caroline Morbach; Laura Obici; Giovanni Palladini; Stefan Störk
Journal:  Curr Heart Fail Rep       Date:  2019-12

Review 3.  Diagnosis and treatment of transthyretin-related amyloidosis cardiomyopathy.

Authors:  Catherine Teng; Pengyang Li; Ju Young Bae; Su Pan; Richard A F Dixon; Qi Liu
Journal:  Clin Cardiol       Date:  2020-07-29       Impact factor: 2.882

Review 4.  Cardiac Amyloidosis Treatment.

Authors:  Lily K Stern; Jignesh Patel
Journal:  Methodist Debakey Cardiovasc J       Date:  2022-03-14

Review 5.  Treatment of Transthyretin Amyloid Cardiomyopathy: The Current Options, the Future, and the Challenges.

Authors:  Carsten Tschöpe; Ahmed Elsanhoury
Journal:  J Clin Med       Date:  2022-04-12       Impact factor: 4.964

6.  Specific Therapy for Transthyretin Cardiac Amyloidosis: A Systematic Literature Review and Evidence-Based Recommendations.

Authors:  Nuno Marques; Olga Azevedo; Ana Rita Almeida; Dina Bento; Inês Cruz; Emanuel Correia; Carolina Lourenço; Luís Rocha Lopes
Journal:  J Am Heart Assoc       Date:  2020-09-24       Impact factor: 5.501

Review 7.  ATTR Amyloidosis: Current and Emerging Management Strategies: JACC: CardioOncology State-of-the-Art Review.

Authors:  Jan M Griffin; Julie L Rosenthal; Justin L Grodin; Mathew S Maurer; Martha Grogan; Richard K Cheng
Journal:  JACC CardioOncol       Date:  2021-10-19
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.